About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Minneapolis | 7,873 Studies Near You

Clinical TrialsMinneapolis

Clinical Trials in Minneapolis

Discover 7,873 clinical trials near Minneapolis, Minnesota. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1101-1120 of 7,873 trials

CompletedSorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive FibromatosisThis randomized phase III trial compares the effects, good and/or bad, of sorafenib tosylate in treating patients with desmoid tumors or aggressive fibromatosis.NCT02066181·Birmingham, Alabama and 149 others

Find Trials by Condition in Minneapolis

Breast Cancerin Minneapolis Lung Cancerin Minneapolis Prostate Cancerin Minneapolis Colorectal Cancerin Minneapolis Melanomain Minneapolis Leukemiain Minneapolis Lymphomain Minneapolis Pancreatic Cancerin Minneapolis Ovarian Cancerin Minneapolis Brain Cancerin Minneapolis

Data from ClinicalTrials.govTerms

Active not recruitingTesting the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyThis phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch…NCT02997228·Kingman, Arizona and 444 others

CompletedA Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)The primary objectives of this study are to assess the efficacy of vonoprazan (10 mg and 20 mg once daily \[QD\]) compared to placebo (QD) in relief of heartburn over 4 weeks in…NCT05195528·Athens, Alabama and 107 others

CompletedClinical Intervention in Alcohol Use DisorderLong-term abstinence from alcohol is supported by a compensatory mechanism in functional brain connectivity, a potential brain biomarker that could be an intervention target.NCT02168400·Minneapolis, Minnesota

TerminatedNew Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis SystemThis post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies.NCT01860092·Los Angeles, California and 16 others

Active not recruitingA Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe HemophiliaThis is a multicenter, multinational, open-label, one-way cross-over, Phase 3, single-arm study for treatment of hemophilia.NCT05662319·Orange, California and 49 others

CompletedAn Efficacy Study of Teriflunomide in Participants With Relapsing Multiple SclerosisThe primary objective of the study was to assess the effect of two doses of teriflunomide, in comparison to placebo, on the frequency of multiple sclerosis (MS) relapses in…NCT00751881·Phoenix, Arizona and 192 others

TerminatedSafety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only SubjectsOpen-label, randomized, controlled, phase 3 safety and efficacy registration trial.NCT03393000·Irvine, California and 12 others

CompletedA Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThis is a randomized, double-blind, placebo-controlled, parallel arm study.NCT01706536·Jasper, Alabama and 25 others

Active not recruitingS0820, Adenoma and Second Primary Prevention TrialThe investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal…NCT01349881·Birmingham, Alabama and 988 others

CompletedEffects of Genotype on CYP2C9 Drug InteractionsThis research study will help determine how a person's genetic makeup affects their responses to drugs, the ability of the body to break down drugs, and their potential to…NCT01061112·Minneapolis, Minnesota

TerminatedLoBAG30 Diet in Patients on MetforminWe will determine the metabolic response to a Low Biologically Available Glucose Diet (LoBAG30) in subjects currently receiving the maximum dose of metformin as monotherapy in…NCT00607867·Minneapolis, Minnesota

CompletedStudy to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and HemodialysisThis is a multicenter, open-label parallel-group to evaluate single oral doses of INCB000928 in participants with varying level of renal function or impairment.NCT05099445·Rialto, California and 4 others

CompletedStudy to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 MutationsThis was a 4-part (Part A, Part B, Part C and Part D), Phase I/IIa, multi-center, open label, study in pediatric subjects with refractory or recurrent tumors.NCT02124772·Phoenix, Arizona and 15 others

TerminatedOpen-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic MalignanciesThe purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.NCT01416428·Scottsdale, Arizona and 18 others

CompletedBortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsRATIONALE: Bortezomib may stop the growth of solid tumors by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00620295·Minneapolis, Minnesota

CompletedEfficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)This is a Phase IIb, randomized, double blind, chronic dosing (28 days), four period, five treatment, incomplete block, crossover design in subjects with moderate to severe COPD.NCT02196077·Rolling Hills Estates, California and 16 others

CompletedDAYLIGHT: Vitamin D Therapy in Individuals at High Risk of HypertensionThis is a randomized, double-blind, multicenter, 6-month follow-up trial of low (400 IU/day) versus high (4000 IU/day) dose vitamin D supplementation in individuals with pre- and…NCT01240512·Hartford, Connecticut and 2 others

CompletedAZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infection.NCT05780437·Tucson, Arizona and 123 others

CompletedRadiosurgery or Open Surgery for Epilepsy TrialThis study will compare radiosurgery (focused radiation, Gamma Knife Radiosurgery) with temporal lobectomy (standard surgical care) as a treatment of temporal lobe epilepsy.NCT00860145·Birmingham, Alabama and 13 others

PreviousPage 56 of 394Next

Diabetes

in Minneapolis

Heart Diseasein Minneapolis